High expression of macrophage migration inhibitory factor in the murine lacrimal gland

Cornea

Volumn 29, Issue 2, 2010, Pages 187-191

  Yong Park, Choul ^a,b   Shin, Young Joo ^a   Lekhanont, Kaevalin ^a   Zhang, Cheng ^a   Lee, Woo Seok ^a   Cano, Marisol ^a   Bucala, Richard ^c   Chuck, Roy S ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Dongguk University College of Medicine   (South Korea)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dry eye; Dysfunctional tear; Inflammation; Inhibition; Lacrimal gland; Macrophage; MIF; Mouse; Ocular surface

Indexed keywords

BETA ACTIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA;

ACINAR CELL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BLOOD SAMPLING; C57BL 6 MOUSE; CBA MOUSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE INFLAMMATION; FEMALE; IMMUNOFLUORESCENCE TEST; LACRIMAL GLAND; LIVER; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN;

ANIMALS; EYE DISEASES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTRAMOLECULAR OXIDOREDUCTASES; LACRIMAL APPARATUS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 77649176416     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181c06466     Document Type: Article

References (32)

1. David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A. 1966;56:72-77.
2. Bacher M, Metz CN, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A. 1996;93:7849-7854. (Pubitemid 26277127)
3. Morand EF, Bucala R, Leech M. Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis. Arthritis Rheum. 2003;48:291-299. (Pubitemid 36277995)
4. Tsuchimoto T, Tubergen DG, Bloom AD. Synthesis of macrophage migration inhibition factor (MIF) by immunoglobulin-producing lymphocyte lines and their clones. J Immunol. 1972;109:884-886.
5. Rocklin RE, Chess L, MacDermott RP, et al. Studies on the production of MIF and mitogenic factor using highly purified human T and B lymphocytes. Rheumatology. 1975;6:98-105.
6. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3:791-800. (Pubitemid 37328657)
7. Brown FG, Nikolic-Paterson DJ, Hill PA, et al. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. J Am Soc Nephrol. 2002;13(Suppl 1):S7-S13.
8. Lan HY, Yang N, Nikolic-Paterson DJ, et al. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int. 2000;57:499-509.
9. Kitaichi N, Kotake S, Sasamoto Y, et al. Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis. Invest Ophthalmol Vis Sci. 1999;40:247-250.
10. Shimizu T, Abe R, Ohkawara A, et al. Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis. Biochem Biophys Res Commun. 1997;240:173-178.
11. Lai KN, Leung JC, Metz CN, et al. Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J Pathol. 2003; 199:496-508.
12. Chagnon F, Metz CN, Bucala R, et al. Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circ Res. 2005;96:1095-1102.
13. Roger T, Chanson AL, Knaup-Reymond M, et al. Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur J Immunol. 2005;35:3405-3413.
14. Bernhagen J, Calandra T, Mitchell RA, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature. 1993;365:756-759. (Pubitemid 23339882)
15. Bernhagen J, Bacher M, Calandra T, et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med. 1996;183:277-282. (Pubitemid 26028767)
16. Lan HY, Bacher M, Yang N, et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med. 1997;185:1455-1465.
17. Kitaichi N, Shimizu T, Honda A, et al. Increase in macrophage migration inhibitory factor levels in lacrimal fluid of patients with severe atopic dermatitis. Graefes Arch Clin Exp Ophthalmol. 2006;244:825-828.
18. Solomon A, Dursun D, Liu Z, et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283-2292.
19. Turner K, Pflugfelder SC, Ji Z, et al. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion. Cornea. 2000;19:492-496.
20. Trousdale MD, Zhu Z, Stevenson D, et al. Expression of TNF inhibitor gene in the lacrimal gland promotes recovery of tear production and tear stability and reduced immunopathology in rabbits with induced autoimmune dacryoadenitis. J Autoimmune Dis. 2005;2:6.
21. Luo L, Li DQ, Doshi A, et al. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004;45: 4293-4301.
22. Foote A, Briganti EM, Kipen Y, et al. Macrophage migration inhibitory factor in systemic lupus erythematosus. J Rheumatol. 2004;31:268-273.
23. Kitaichi N, Kotake S, Mizue Y, et al. Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitis. Br J Ophthalmol. 2000;84:1423-1425.
24. Pflugfelder SC, Solomon A, Dursun D, et al. Dry eye and delayed tear clearance: A call to arms. Adv Exp Med Biol. 2002;506:739-743.
25. Shimizu T, Ogata A, Honda A, et al. Expression of macrophage migration inhibitory factor in rat skin during embryonic development. Exp Dermatol. 2005;14:819-823.
26. Wilson JM, Coletta PL, Cuthbert RJ, et al. Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology. 2005;129:1485-1503.
27. Martin C, Roger T, Calandra T. Evolving concepts in sepsis and septic shock. In: Eichacker PQ, Pugin J, eds. Evolving Concepts in Sepsis and Septic Shock. Boston, MA: Kluwer Academic Publishers; 2001:45-67.
28. Baugh JA, Bucala R. Macrophage migration inhibitory factor. Crit Care Med. 2002;30(1 suppl):S27-S35.
29. Lue H, Kleemann R, Calandra T, et al. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect. 2002;4:449-460.
30. Calandra T, Bernhagen J, Mitchell RA, et al. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 1994;179:1895-1902. (Pubitemid 24155670)
31. Bacher M, Meinhardt A, Lan HY, et al. Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol. 1997; 150:235-246.
32. Fingerle-Rowson G, Koch P, Bikoff R, et al. Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am J Pathol. 2003;162:47-56. (Pubitemid 36041989)